Research programme: tocotrienols - LipoGenics
Alternative Names: Tocotrienols - LipoGenicsLatest Information Update: 24 Apr 2007
At a glance
- Originator LipoGenics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia
Most Recent Events
- 24 Apr 2007 Discontinued - Preclinical for Benign prostatic hyperplasia in USA (unspecified route)
- 01 Mar 2001 Preclinical development for Benign prostatic hyperplasia in USA (Unknown route)